Akrivis Pharma Private Limited
About Akrivis Pharma Private Limited
Data last updated:
Akrivis Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 12 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24302TG2018PTC123779. Its GSTIN is 36AAQCA7782C2ZB (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anjiraju Siddiraju and Ravi Kumar Pigili.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No – 205 Block No – E Ncl Lb Godhavari Petbasheerabad, Hyderabad, Telangana, India – 500055.
Company details
Contact details
Akrivis Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No – 205 Block No – E Ncl Lb Godhavari Petbasheerabad, Hyderabad, Telangana, India – 500055
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Akrivis Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Akrivis Pharma is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Akrivis Pharma Private Limited, buy the company report.
Financials of Akrivis Pharma Private Limited
FY 2025 filings availableAkrivis Pharma Private Limited reported revenue of ₹315 (down 100% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 82% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Akrivis Pharma Private Limited, buy the company report.
Board of directors of Akrivis Pharma Private Limited
Akrivis Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anjiraju Siddiraju | Director | 12 Apr 2018 | 8 Years 6 Months | Current |
| Ravi Kumar Pigili | Director | 12 Apr 2018 | 8 Years 6 Months | Current |
Auditor
Akrivis Pharma Private Limited is audited by MANDAVA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANDAVA & ASSOCIATES | FY 2023 | 015233S |
Shareholding
The shareholding of Akrivis Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Akrivis Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Akrivis Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Akrivis Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Akrivis Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAQCA7782C2ZB | Telangana | Active | 09 Nov 2020 |
To see the full GST registrations and return filing status of Akrivis Pharma Private Limited, buy the company report.
Recent activity
Akrivis Pharma Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Anjiraju Siddiraju was appointed as Director on 12 Apr 2018.
Frequently asked questions
Akrivis Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 12 April 2018 (8+ years old) and is registered under CIN U24302TG2018PTC123779.
Akrivis Pharma has 2 current directors:
- Anjiraju Siddiraju - Director
- Ravi Kumar Pigili - Director
The latest financial statements of Akrivis Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Akrivis Pharma is 36AAQCA7782C2ZB, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Akrivis Pharma is U24302TG2018PTC123779. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Akrivis Pharma was incorporated on 12 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
Anjiraju Siddiraju was appointed as Director on 12 Apr 2018. Ravi Kumar Pigili was appointed as Director on 12 Apr 2018.
The registered office of Akrivis Pharma is at Flat No – 205 Block No – E Ncl Lb Godhavari Petbasheerabad, Hyderabad, Telangana, India – 500055.
Akrivis Pharma operates in the pharma industry, in the pharma contract r and d segment.
Akrivis Pharma can be reached at its registered office: Flat No – 205 Block No – E Ncl Lb Godhavari Petbasheerabad, Hyderabad, Telangana, India – 500055.